The role of sublingual sufentanil nanotabs for pain relief

Harold S. Minkowitz, Keith A Candiotti

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Introduction: The authors discuss a novel patient controlled analgesia system utilizing a preprogrammed device that delivers a small submucosal tablet of sufentanil.Areas covered: This submucosal sufentanil system is not yet commercially available. A literature review of the current patient controlled analgesia systems and current information of this device are discussed.Expert opinion: This novel device has the potential to enhance patient safety as it is preprogrammed and delivers a standard dose of sufentanil, a rapidly acting opioid devoid of active metabolites.

Original languageEnglish (US)
Pages (from-to)845-851
Number of pages7
JournalExpert Opinion on Drug Delivery
Volume12
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Sufentanil
Patient-Controlled Analgesia
Pain
Equipment and Supplies
Expert Testimony
Patient Safety
Information Systems
Opioid Analgesics
Tablets

Keywords

  • Microtablet
  • Pain
  • Sublingual
  • Sufentanil

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

The role of sublingual sufentanil nanotabs for pain relief. / Minkowitz, Harold S.; Candiotti, Keith A.

In: Expert Opinion on Drug Delivery, Vol. 12, No. 5, 01.05.2015, p. 845-851.

Research output: Contribution to journalArticle

@article{558946a4600f4376a7fc6c43e6f4eb54,
title = "The role of sublingual sufentanil nanotabs for pain relief",
abstract = "Introduction: The authors discuss a novel patient controlled analgesia system utilizing a preprogrammed device that delivers a small submucosal tablet of sufentanil.Areas covered: This submucosal sufentanil system is not yet commercially available. A literature review of the current patient controlled analgesia systems and current information of this device are discussed.Expert opinion: This novel device has the potential to enhance patient safety as it is preprogrammed and delivers a standard dose of sufentanil, a rapidly acting opioid devoid of active metabolites.",
keywords = "Microtablet, Pain, Sublingual, Sufentanil",
author = "Minkowitz, {Harold S.} and Candiotti, {Keith A}",
year = "2015",
month = "5",
day = "1",
doi = "10.1517/17425247.2015.975202",
language = "English (US)",
volume = "12",
pages = "845--851",
journal = "Expert Opinion on Drug Delivery",
issn = "1742-5247",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - The role of sublingual sufentanil nanotabs for pain relief

AU - Minkowitz, Harold S.

AU - Candiotti, Keith A

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Introduction: The authors discuss a novel patient controlled analgesia system utilizing a preprogrammed device that delivers a small submucosal tablet of sufentanil.Areas covered: This submucosal sufentanil system is not yet commercially available. A literature review of the current patient controlled analgesia systems and current information of this device are discussed.Expert opinion: This novel device has the potential to enhance patient safety as it is preprogrammed and delivers a standard dose of sufentanil, a rapidly acting opioid devoid of active metabolites.

AB - Introduction: The authors discuss a novel patient controlled analgesia system utilizing a preprogrammed device that delivers a small submucosal tablet of sufentanil.Areas covered: This submucosal sufentanil system is not yet commercially available. A literature review of the current patient controlled analgesia systems and current information of this device are discussed.Expert opinion: This novel device has the potential to enhance patient safety as it is preprogrammed and delivers a standard dose of sufentanil, a rapidly acting opioid devoid of active metabolites.

KW - Microtablet

KW - Pain

KW - Sublingual

KW - Sufentanil

UR - http://www.scopus.com/inward/record.url?scp=84928329654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928329654&partnerID=8YFLogxK

U2 - 10.1517/17425247.2015.975202

DO - 10.1517/17425247.2015.975202

M3 - Article

C2 - 25388859

AN - SCOPUS:84928329654

VL - 12

SP - 845

EP - 851

JO - Expert Opinion on Drug Delivery

JF - Expert Opinion on Drug Delivery

SN - 1742-5247

IS - 5

ER -